These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 11785519)
21. The Cipro patent and bioterrorism. Kaye KS; Kaye D Am J Bioeth; 2002; 2(3):41-2. PubMed ID: 12230854 [No Abstract] [Full Text] [Related]
22. Authorized generics. Glass G Nat Rev Drug Discov; 2005 Dec; 4(12):953-4. PubMed ID: 16370080 [No Abstract] [Full Text] [Related]
23. Face-off will new drugs pay off in time to counter patent losses for Forest Laboratories? Vukhac K; Rivkind I Fortune; 2012 Jun; 165(8):80. PubMed ID: 22741415 [No Abstract] [Full Text] [Related]
24. A few specialty drug prices fall--all generics. Manag Care; 2008 Dec; 17(12):46. PubMed ID: 19127766 [No Abstract] [Full Text] [Related]
26. Compulsory licensure: the case of Cipro and beyond. Chakrabarty AM Am J Bioeth; 2002; 2(3):40. PubMed ID: 12230853 [No Abstract] [Full Text] [Related]
27. Pharmaceutical policy in Italy: towards a structural change? Ghislandi S; Krulichova I; Garattini L Health Policy; 2005 Apr; 72(1):53-63. PubMed ID: 15760698 [TBL] [Abstract][Full Text] [Related]
28. The ongoing regulation of generic drugs. Frank RG N Engl J Med; 2007 Nov; 357(20):1993-6. PubMed ID: 18003956 [No Abstract] [Full Text] [Related]
30. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity. Berger JM Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292 [No Abstract] [Full Text] [Related]
31. Justices expand rights to experiment with patented drugs. Pollack A N Y Times Web; 2005 Jun; ():C1, C8. PubMed ID: 15966121 [No Abstract] [Full Text] [Related]
32. Why do the same drugs look different? Pills, trade dress, and public health. Greene JA; Kesselheim AS N Engl J Med; 2011 Jul; 365(1):83-9. PubMed ID: 21732842 [No Abstract] [Full Text] [Related]
33. Policy on 180-day marketing exclusivity for drugs marketed under abbreviated new drug applications; clarification--FDA. Clarification. Fed Regist; 1997 Nov; 62(229):63268-9. PubMed ID: 10177950 [TBL] [Abstract][Full Text] [Related]
34. Pharmaceuticals and medical devices: cost savings. ; Steiner DJ Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403843 [No Abstract] [Full Text] [Related]
35. Possible anticompetitive agreements between brand, generic companies to be studied. Landis NT Am J Health Syst Pharm; 2000 Dec; 57(23):2140, 2142. PubMed ID: 11127691 [No Abstract] [Full Text] [Related]